Atlas Trials

Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD)

Clinical trial NCT02525263 · TERMINATED

Trial details

NCT number
NCT02525263
Sponsor
Prokidney
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Kidney DiseaseType 2 Diabetes
Start date
2016-07-01
Primary completion
2017-05-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.